Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurely

In patients receiving anticoagulation for deep vein thrombosis (DVT), a variety of reasons (including active bleeding or high-risk for bleeding) may lead into premature discontinuation of therapy (prior to completing 90  days). The relative frequency and clinical consequences of premature discontinuation in contemporary patients remain unknown.

Source: Thrombosis Research - March 4, 2020 Category: Hematology Authors: Jos é A. Nieto, Damian Mora, Behnood Bikdeli, Montserrat Perez Pinar, Reina Valle, José María Pedrajas, Isabelle Mahé, José González-Martínez, María del Carmen Díaz-Pedroche, Manuel Monreal, the RIETE Investigators Tags: Review Article Source Type: research